Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
5
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 5 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Reclast* Zoledronic Acid/Mannitol-Water* · J3489 | B | $4.2M | -21% | 96,550 | $43 | $6.48 |
| Zoledronic Acid Zoledronic Acid/Mannitol-Water | D | $1.6M | -14% | 10,061 | $156 | $1.54 |
| Zoledronic Acid Zoledronic Acid | D | $438K | -44% | 1,238 | $354 | $21.58 |
| Reclast Zoledronic Acid/Mannitol-Water | D | $106K | +24% | 104 | $1,015 | $10.05 |
| Zoledronic Acid Zoledronic Ac/Mannitol/0.9nacl | D | $86K | +18% | 204 | $422 | $1.48 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.